U.S. Markets closed
  • S&P Futures

    4,118.75
    -4.25 (-0.10%)
     
  • Dow Futures

    33,951.00
    -45.00 (-0.13%)
     
  • Nasdaq Futures

    13,213.25
    +1.25 (+0.01%)
     
  • Russell 2000 Futures

    2,207.70
    -0.20 (-0.01%)
     
  • Crude Oil

    65.02
    -0.47 (-0.72%)
     
  • Gold

    1,871.20
    +3.20 (+0.17%)
     
  • Silver

    28.31
    -0.03 (-0.10%)
     
  • EUR/USD

    1.2232
    +0.0006 (+0.0489%)
     
  • 10-Yr Bond

    1.6420
    +0.0020 (+0.12%)
     
  • Vix

    21.34
    +1.62 (+8.22%)
     
  • GBP/USD

    1.4189
    +0.0002 (+0.0142%)
     
  • USD/JPY

    109.0040
    +0.1140 (+0.1047%)
     
  • BTC-USD

    42,703.10
    -1,624.57 (-3.66%)
     
  • CMC Crypto 200

    1,197.99
    -55.16 (-4.40%)
     
  • FTSE 100

    7,034.24
    +1.39 (+0.02%)
     
  • Nikkei 225

    27,973.06
    -433.78 (-1.53%)
     

Travere Therapeutics to Host Virtual R&D Day on Wednesday, December 9, 2020

  • Oops!
    Something went wrong.
    Please try again later.
Travere Therapeutics, Inc.
·2 min read
  • Oops!
    Something went wrong.
    Please try again later.

SAN DIEGO, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Travere Therapeutics (NASDAQ: TVTX) today announced that the Company will host a virtual R&D Day on Wednesday, December 9, 2020 at 12:00 p.m. ET to review the Company’s key pipeline programs. The event will feature presentations from external experts and the Travere Therapeutics senior management team.

Presenters:

  • Jonathan Hogan, M.D., assistant professor of medicine at the Perelman School of Medicine, University of Pennsylvania, & clinical director, Penn Glomerular Center

  • Jonathan Barratt, Ph.D., FRCP, Mayer professor of renal medicine at the University of Leicester & John Walls Renal Unit, Leicester

  • Eric Dube, Ph.D., chief executive officer at Travere Therapeutics

  • Noah Rosenberg, M.D., chief medical officer at Travere Therapeutics

  • William Rote, Ph.D., senior vice president of research and development at Travere Therapeutics

  • Peter Heerma, chief commercial officer at Travere Therapeutics

Virtual R&D Day Information:

  • Date: Wednesday, December 9, 2020

  • Time: 12:00 p.m. ET (9:00 a.m. PT)

  • Live webcast: Travere.com in the “Events & Presentations” section of the “Investors and Media” Page

A replay of the webcast will be available at https://ir.travere.com/events-presentations and will be accessible for up to 60 days.

About Travere Therapeutics

At Travere Therapeutics we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com

Contact:
Chris Cline, CFA
Senior Vice President, Investor Relations & Corporate Communications
888-969-7879
IR@travere.com